Curevac N.V. buy shadow
Start price
10.09.20
/
0%
€48.40
Target price
04.11.21
-
Performance (%)
-26.12%
End price
05.11.21
€35.76
Summary
This prediction ended on 05.11.21 with a price of €35.76. The price of Curevac N.V. has decreased during the runtime of the prediction. Compared to the start price this resulted in a performance of -26.12%.Performance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Curevac N.V. | 5.450% | 5.450% | - | - |
| iShares Core DAX® | 2.112% | -0.367% | 13.466% | 16.854% |
| iShares Nasdaq 100 | -2.197% | -3.794% | 38.426% | 42.934% |
| iShares Nikkei 225® | -1.555% | -7.320% | 18.451% | 2.941% |
| iShares S&P 500 | -0.472% | -2.078% | 27.488% | 41.955% |
According to shadow what are the pros and cons of Curevac N.V. for the foreseeable future?
Pros
Revenue growth >5% per year expected
Higher EBIT margin than peer group
positive Cash Flow expected
Standard Investments for future growth
Valuable balance sheet
ROE higher than 10% per year
Capable Management
Good culture
Innovative
Differentiated customer and product portfolio
Top 10 in its market
Future proof or reliable business model
Could be worthwhile Investment >10% per year
Fair valuation
EBIT growth >5% per year expected
Some uniques
Growths faster than the competition
Known brand
Cons
Increased challenges to pay loans and raise capital
Sustainability is little important
Significant cyclical dependencies
high free float
Low dividend yield expected
Higher risks for its business
Bad rating
Comments by shadow for this prediction
In the thread Curevac N.V. diskutieren
Buy Curevac N.V.
In the thread Trading Curevac N.v.
Die von shadow gewählte maximale Laufzeit wurde überschritten